A single-cell landscape of high-grade serous ovarian cancer

A single-cell landscape of high-grade serous ovarian cancer

© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc. Malignant abdominal fluid (ascites) frequently develops in women with advanced high-grade serous ovarian cancer (HGSOC) and is associated with drug resistance and a poor prognosis1. To comprehensively characterize the HG...

Full description

Bibliographic Details
Format:	Article
Language:	English
Published:	Springer Science and Business Media LLC 2021
Online Access:	https://hdl.handle.net/1721.1/136662

Similar Items

A single-cell landscape of high-grade serous ovarian cancer
by: Izar, Benjamin, et al.
Published: (2022)

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Published: (2018)

Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
Published: (2021)

Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
Published: (2022)

Biallelic NF1 inactivation in high grade serous ovarian cancers from patients with neurofibromatosis type 1
by: Courtney, Eliza, et al.
Published: (2022)

RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors
by: Dreaden, Erik, et al.
Published: (2018)

Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma
by: Tang, Zhiqun, et al.
Published: (2016)

Ovarian cancer? Wait for results
by: Azizan, Azha Syahril, et al.
Published: (2010)

Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer
by: Emmons, Tiffany R, et al.
Published: (2021)

Cytotoxic Effects of Zerumbone on Ovarian and Cervical Cancer Cell Lines
by: Mohd Zain, Zetty Nadia
Published: (2005)

Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer
by: Emmons, Tiffany R., et al.
Published: (2022)

Niosome Encapsulation of Curcumin: Characterization and Cytotoxic Effect on Ovarian Cancer Cells
by: Xu, Ying-Qi, et al.
Published: (2016)

Zerumbone inhibits interleukin-6 and induces apoptosis and cell cycle arrest in ovarian and cervical cancer cells
by: Abdelwahab, S.I., et al.
Published: (2012)

Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
by: Ren, Yin, et al.
Published: (2012)

Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer
by: Lee, T. I., et al.
Published: (2020)

Optimized icariin cubosomes exhibit augmented cytotoxicity against SKOV-3 ovarian cancer cells
by: A. Fahmy, Usama, et al.
Published: (2021)

Effect of kenaf seed oil from different ways of extraction towards ovarian cancer cells.
by: Saiful Yazan , Latifah, et al.
Published: (2011)

Ovarian Cancer Ascites Inhibits Transcriptional Activation of NK Cells Partly through CA125
by: Fraser, Christopher C, et al.
Published: (2023)

Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
by: Lauffer, Sam, et al.
Published: (2018)

A multiresolution framework to characterize single-cell state landscapes
by: Mohammadi, Shahin, et al.
Published: (2021)

Dissecting the complex landscape of neuroinflammation at single-cell resolution
by: Raju, Ravikiran M., et al.
Published: (2019)

Inhibitory effects of leaf extract of Apama tomentosa on ovarian cancer
by: Lee, I.L., et al.
Published: (2008)

Assessment of risk factors for breast and ovarian cancer in UMS students
by: Ohnmar Myint, et al.
Published: (2018)

Extracellular vesicles and their detection with plasmonic bionsensors for the diagnosis of ovarian cancer
by: Reiner, Agnes
Published: (2018)

An intraperitoneal implantable drug delivery device for the treatment of ovarian cancer
by: Ye, Hongye
Published: (2014)

Layer-by-Layer Nanoparticles for Targeted Delivery and Treatment of Ovarian Cancer
by: Kong, Stephanie Mabel
Published: (2022)

Plagioneurin B, a potent isolated compound induces apoptotic signalling pathways and cell cycle arrest in ovarian cancer cells
by: Nordin, Noraziah, et al.
Published: (2018)

En Face Enhanced-Depth Swept-Source Optical Coherence Tomography Features of Chronic Central Serous Chorioretinopathy
by: Ferrara, Daniela, et al.
Published: (2015)

VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients
by: Khan, ANM N. H., et al.
Published: (2022)

Geometric Sketching Compactly Summarizes the Single-Cell Transcriptomic Landscape
by: Hie, Brian, et al.
Published: (2021)

CRISPRi screens to identify combination therapies for the improved treatment of ovarian cancer
by: Handly, Erika Daphne.
Published: (2021)

O-CareCloud: ovarian cancer patient management system on cloud
by: Latip, Rohaya, et al.
Published: (2014)

Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
by: Shafiee MN,, et al.
Published: (2013)

Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer
by: Fong, M.Y., et al.
Published: (2011)

Chemotherapy-Eluting Intraperitoneal Implants for Advanced Stage Ovarian Cancer Treatment
by: Subramanyam, Kriti S.
Published: (2022)

Design of an intraperitoneal drug-release device for advanced ovarian cancer therapy
by: Tanenbaum, Laura Melanie
Published: (2016)

Engineering layer-by-layer nanoparticles for the targeted delivery of therapeutics to ovarian cancer
by: Correa, Santiago (Santiago Correa Echavarria)
Published: (2019)

MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
by: Kumar, Smriti R., et al.
Published: (2011)

Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
by: Lauffer, Sam, et al.
Published: (2018)

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families
by: Kang, P., et al.
Published: (2010)